Compare Liquidia Corporation Common Stock (LQDA) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Nuscale Power Corporation — how do they compare? Liquidia Corporation Common Stock trades at $33.81 (market cap $3.04B), while Nuscale Power Corporation trades at $5.64 (market cap $2.39B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nuscale Power Corporation for 30 Days on average.
| LQDA | SMR | |
|---|---|---|
Market Cap | $3.04B | $2.39B |
Volume | 21,111,778 | 42,309,613 |
Sector | Health | Industrials |
52-Week High | $91.03 | $53.43 |
52-Week Low | $22.02 | $5.83 |
Typical Hold Time | 0 Days | 30 Days |
Enterprise Value | $2.94B | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NuScale Power (SMR) trades at $6.495, down 3.06% today, with bearish technical signals dominating despite some oversold RSI readings. The company shows severe financial strain with negative net income margins of -3,888.7% and operating cash flow deficits, though it maintains strong analyst support with a $11.25 consensus price target. Recent news highlights ongoing legal investigations and competitive pressures in the nuclear energy sector.
The stock faces significant fundamental challenges with massive losses and cash burn, but offers speculative upside if commercialization efforts succeed. Key risks include execution missteps, dilution concerns, and intense SMR competition. With 50% analyst buy ratings but bearish technicals, SMR represents a high-risk, high-reward opportunity in the emerging nuclear energy space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
